Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

Viewing Page 2 of 4 | Showing Results 6 - 10 of 18

A Randomized, Double-Blind, Phase 3 Comparison of Platinum-Based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-Based Therapy as First-Line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer

This is a global, multicenter, randomized, double-blind, controlled Phase 3 study in patients with newly diagnosed, Stage III or IV non mucinous...

Joanie Hope MD
  • Alaska Research
  • Alaska Women's Cancer Care
  • Kadlec Research
  • Providence Alaska Medical Center

A Novel Approach Applying CGM Metrics to Identify a Prediabetic State

(1) Be willing to give informed consent (and assent if appropriate) for the CGM study.(2) Be aged 2-50 years. (3) Be not eligible for or have...

Steven Kunkel, M.D.
  • Kadlec Diabetes Learning Center
  • Kadlec Research

Natural History Study of the Development of Type 1 Diabetes.

(1) First degree relatives (age 1 – 45 years) of T1D probands. (2) Second and third degree relatives (age 1 – 20 years) of T1D probands: nieces,...

Steven Kunkel, M.D.
  • Kadlec Diabetes Learning Center
  • Kadlec Research

KHO SGN35-027 - Multiple Part Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma Subjects

This is an open-label, multiple part, multicenter, phase 2 clinical trial. Part A will assess the incidence of febrile neutropenia, efficacy, and...

Rangaswamy Chintapatla, M.D.
  • Kadlec Clinic Hematology and Oncology
  • Kadlec Research

A phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of anamorelin HCl for the treatment of malignancy associated weight loss and anorexia in adult patients with advanced non-small cell lung cancer (NSCLC)

Inclusion Criteria:1.Signed written informed consent2.Female or male ≥18 years of age3.Documented histologic or cytologic diagnosis of American...

Ying Zhuo, M.D.
  • Kadlec Clinic Hematology and Oncology
  • Kadlec Research
Viewing Page 2 of 4 | Showing Results 6 - 10 of 18